Primary biliary cirrhosis clinical research single-topic conference

Hepatology

Volumn 23, Issue 3, 1996, Pages 639-644

  Lindor, Keith D ^a   Hoofnagle, Jay ^b   Madorey, Willis C ^c   Mackay, Ian R ^d   Rolland Dickson, E ^a  

^a MAYO CLINIC   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BILIARY CIRRHOSIS; CLINICAL FEATURE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; LIVER DISEASE; MEDICAL RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029984443     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230332     Document Type: Review

References (5)

1. Laurin JM, Lindor KD. Primary biliary cirrhosis. Dig Dis 1994;12:331-350.
2. Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991;100:822-833.
3. Teoh KL, Rowley MJ, Zafirakis H, Dickson ER, Wiesner RH, Gershwin ME, Mackay IR. Enzyme inhibitory antibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: applications of a semi-automated assay. HEPATOLOGY 1994; 20:1220-1224.
4. VanDeWater J, Turchany J, Leung PSC, Lake J, Munoz S, Surh CD, Coppel R. Molecular mimicry in primary biliary cirrhosis: evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex E2. J Clin Invest 1993;91:2653-2664.
5. Mehal WZ, Gregory WL, Lo D, Cross SJ, Fleming KA, Bassendine MF, James OFW, et al. Defining the immunogenetic susceptibility to primary biliary cirrhosis. HEPATOLOGY 1994;20:1213-1219.